---
title: "PRIVATE MEDS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f1b8387c-9d7f-5192-a98f-45efaffc4966
json: https://whiteintel.dev/api/public/dossier/f1b8387c-9d7f-5192-a98f-45efaffc4966
identifier: oo:GB-COH-06494908
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# PRIVATE MEDS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06494908`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f1b8387c-9d7f-5192-a98f-45efaffc4966  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f1b8387c-9d7f-5192-a98f-45efaffc4966  

## Ownership & control

### Owners / controllers

- **PHARMACY2U LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/499ac74c-12ce-58af-a0d7-72017ff5e5f4
- **PHARMACY2U LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/499ac74c-12ce-58af-a0d7-72017ff5e5f4

### UBO chain (walk to the ultimate owner)

A **54-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06494908`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2008-02-06
- **Registered office:** Lumina Park Approach, Thorpe Park, Leeds, LS15 8GB, England
- **SIC:** 86210

### Officers

- DANNATT, Gary John — director · British · appointed 2018-03-29
- FAWCETT, Scott Lee — director · British · appointed 2023-02-01
- HEATH, Kevin John — director · British · appointed 2022-12-14
- YORK PLACE COMPANY SECRETARIES LIMITED — corporate secretary · appointed 2008-02-06 · resigned 2012-08-06
- BREWARD, Andrew — director · British · appointed 2008-02-06 · resigned 2012-08-10
- FAWCETT, Scott Lee — director · British · appointed 2013-01-16 · resigned 2018-03-29
- HARRISON, Julian Earle — director · British · appointed 2012-08-10 · resigned 2016-12-31
- LEE, Daniel Mark — director · British · appointed 2012-08-10 · resigned 2019-06-06
- LIVINGSTONE, Mark Jonathan Charles — director · British · appointed 2018-03-29 · resigned 2022-12-14
- SHORI, Nitin, Dr — director · British · appointed 2010-12-24 · resigned 2012-08-10
- TAVERNER, Colin — director · British · appointed 2012-08-10 · resigned 2013-01-16

### Beneficial owners (Persons with Significant Control)

- [Pharmacy2u Limited](https://whiteintel.dev/entity/499ac74c-12ce-58af-a0d7-72017ff5e5f4) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06494908
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06494908

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **PRIVATE MEDS LIMITED**. Human view: https://whiteintel.dev/entity/f1b8387c-9d7f-5192-a98f-45efaffc4966 · Structured JSON: https://whiteintel.dev/api/public/dossier/f1b8387c-9d7f-5192-a98f-45efaffc4966._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._